BJ
SBBP

BlackRock Japan’s Strongbridge Biopharma plc. SBBP Stock Holding History

BlackRock Japan’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Sell
1,604
-105
-6% -$428 ﹤0.01% 1271
2016
Q3 		$9K Sell
1,709
-133
-7% -$600 ﹤0.01% 1222
2016
Q2 		$7K Sell
1,842
-18
-1% -$85 ﹤0.01% 1320
2016
Q1 		$8K Hold
1,860
– – ﹤0.01% 1316
2015
Q4 		$14K Buy
+1,860
New +$13.4K ﹤0.01% 1227

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

BlackRock Japan's SBBP Position: Q4 2016 in Review

BlackRock Japan reduced its Strongbridge Biopharma plc. (SBBP) stake by 6.1% in Q4 2016, selling an estimated $428 and leaving 1,604 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

BlackRock Japan first reported a position in SBBP in Q4 2015 and has held it in 5 quarters since. The position peaked at $14K in Q4 2015. 18 funds tracked by Wall St. Rank hold SBBP as of Q4 2016.

  • BlackRock Japan held 1,604 shares of Strongbridge Biopharma plc. worth $4K as of Q4 2016.
  • BlackRock Japan sold 105 Strongbridge Biopharma plc. shares in Q4 2016, an estimated $428.
  • Strongbridge Biopharma plc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1271 holding.
  • BlackRock Japan first reported a position in Strongbridge Biopharma plc. in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Japan's Strongbridge Biopharma plc. position peaked at $14K in Q4 2015.
  • 18 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.